The Philippines has the fourth highest TB burden in the world and contributes 7% of global cases, behind India (27%), Indonesia (10%), and China (7.1%), according to the World Health Organization’s Global TB Report 2021. But for the archipelagic country with 7,640 islands, citizens’ access to healthcare and diagnostic tools has been one of the greatest barriers to addressing TB.

CANBERRA (25 March 2024)—The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Alliance through its Product Development and Access Partnerships program. The funding will contribute toward the completion of the NC-009 Pan-Phase 2 clinical trial and also help establish and sustain the Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub in Manila, which will disseminate best practices to help speed the programmatic implementation of innovative, effective tuberculosis treatments, including the World Health Organization (WHO) recommended six-month, all-oral BPaL/M regimens for drug-resistant tuberculosis (DR-TB).

On World TB Day, WHO is calling for action on several fronts to ensure that the commitments made to end TB are achieved. A special newsletter edition compiles all WHO advocacy activities and key resources released in the lead-up to World TB Day.

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!

TB advocates protest outside the headquarters of Danaher in Washington, DC, demanding price drop to $5 per test.

Scientists have taken a major step towards developing a blood test that could identify millions of people who spread tuberculosis unknowingly.

Early detection and prompt treatment of tuberculosis (TB) are the main pillars on the way to ending TB as they help prevent further transmission. Finding those at risk of developing infection, however, requires extra efforts, particularly in settings where TB incidence levels are generally low, i.e., when there are less than 10 TB cases per 100,000 population.

Results UK’s new advocacy report presents the case for adopting a whole of society approach to ending TB, focused on addressing the underlying social causes of TB alongside curing the physical disease.

Nearly 7,000 excess deaths from TB occurred in the WHO European Region in the three years of the pandemic from 2020-2022, compared to what experts had expected based on pre-2020 estimates.